Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AORTIC 2017 /
Treating Burkitt's lymphoma in Kampala

7th - 10th Nov 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.11.17
Views: 1273

Dr Avram Denburg - University of Toronto Toronto, Canada

Dr Denburg speaks with ecancer at AORTIC 2017 about a trial to assess cost-effectiveness of treating Burkitt's lymphoma, a common childhood cancer, in Uganda.

He sets out the measures used to assess cost-effectiveness, noting the difference between that and affordability, and reports that interventions were found to be very cost effective.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation